Patents Assigned to Epoplus GmbH & Co. KG
  • Publication number: 20100247451
    Abstract: The present invention relates to the use of erythropoietin for stimulating the physiological mobilization, proliferation and differentiation of endothelial progenitor cells, for stimulating vasculogenesis, for the therapy of diseases associated with a dysfunction of endothelial progenitor cells and for producing pharmaceutical compositions for the treatment of such diseases, and pharmaceutical compositions which comprise erythropoietin and other suitable active ingredients for stimulating endothelial progenitor cells.
    Type: Application
    Filed: April 13, 2010
    Publication date: September 30, 2010
    Applicant: EPOPLUS GMBH & CO. KG
    Inventors: Ferdinand Hermann Bahlmann, Hermann Haller
  • Publication number: 20100247452
    Abstract: The present invention relates to the use of erythropoietin for stimulating the physiological mobilization, proliferation and differentiation of endothelial progenitor cells, for stimulating vasculogenesis, for the therapy of diseases associated with a dysfunction of endothelial progenitor cells and for producing pharmaceutical compositions for the treatment of such diseases, and pharmaceutical compositions which comprise erythropoietin and other suitable active ingredients for stimulating endothelial progenitor cells.
    Type: Application
    Filed: April 13, 2010
    Publication date: September 30, 2010
    Applicant: EPOPLUS GMBH & CO. KG
    Inventors: Ferdinand Hermann Bahlmann, Hermann Haller
  • Publication number: 20100247450
    Abstract: The present invention relates to the use of erythropoietin for stimulating the physiological mobilization, proliferation and differentiation of endothelial progenitor cells, for stimulating vasculogenesis, for the therapy of diseases associated with a dysfunction of endothelial progenitor cells and for producing pharmaceutical compositions for the treatment of such diseases, and pharmaceutical compositions which comprise erythropoietin and other suitable active ingredients for stimulating endothelial progenitor cells.
    Type: Application
    Filed: April 13, 2010
    Publication date: September 30, 2010
    Applicant: EPOPLUS GMBH & CO. KG
    Inventors: Ferdinand Hermann Bahlmann, Hermann Haller
  • Patent number: 7745387
    Abstract: The present invention relates to the use of erythropoietin for stimulating the physiological mobilization, proliferation and differentiation of endothelial progenitor cells, for stimulating vasculogenesis, for the therapy of diseases associated with a dysfunction of endothelial progenitor cells and for producing pharmaceutical compositions for the treatment of such diseases, and pharmaceutical compositions which comprise erythropoietin and other suitable active ingredients for stimulating endothelial progenitor cells.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: June 29, 2010
    Assignee: Epoplus GmbH & Co. KG
    Inventors: Ferdinand Hermann Bahlmann, Hermann Haller